Pandemic influenza vaccine（inactivated，adjuvanted）

大流行流感病毒灭活疫苗（北京科兴生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePandemic influenza vaccine（inactivated，adjuvanted）
Drug Alias NameH5N1 influenza vaccine (Sinovac)大流行流感病毒灭活疫苗盼尔来福Panflu
ClassificationVaccines > Biological material > Viral vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2008/04/02
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinovac Biotech Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSinovac Biotech Ltd
Inactive CompaniesSinovac Biotech Co Ltd
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB01
Related LinksN/A